Ian Deveau PhD U.S. FDA

Ian Deveau PhD

Ian Deveau PhD U.S. FDA Division Director, OC, CDER

Ian Deveau, PhD, Division Director (Acting), Office of Manufacturing Quality, Office of Compliance, CDER
Dr. Deveau oversees the efforts to protect the American public from poor quality drug products and ensure compliance of firms authorized by sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FDCA).
Dr. Deveau is a subject matter expert on sterile drug production, Current Good Manufacturing Practices (21 CFR 210, 211 & 212), and pharmacy compounding practices (USP <795> and <797>).
Dr. Deveau holds a Bachelor’s degree in Biology from Buffalo State University; and a PhD in Biology from The Pennsylvania State University with minors in Microbiology, Chemistry, and Biochemistry.
Prior to joining CDER, he was a chemist and GLP Study Director at FDA’s Center for Veterinary Medicine, followed by 9 years at the U.S. Pharmacopeia involved in developing standards for microbial control of drug manufacturing, blood and blood products, vaccines, biologics and biotechnology products, radiopharmaceuticals & medical imaging agents, and veterinary drugs.